Zydus Lifesciences Ltd. on Thursday, January 15, informed stock exchanges that it has secured final approval from the US Food and Drug Administration for...
Marksans Pharma’s fully owned UK subsidiary, Relonchem Limited, has received authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to market Mefenamic...